BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 2 filers reported holding BRIDGEBIO PHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,370 | -78.5% | 1,986 | -86.0% | 0.00% | -75.0% |
Q2 2023 | $243,534 | +338141.7% | 14,159 | +222.7% | 0.01% | +300.0% |
Q1 2023 | $72 | +44.0% | 4,388 | -32.3% | 0.00% | 0.0% |
Q4 2022 | $50 | -100.0% | 6,484 | -61.4% | 0.00% | -33.3% |
Q3 2022 | $167,000 | -44.0% | 16,795 | -48.8% | 0.00% | -57.1% |
Q2 2022 | $298,000 | +66.5% | 32,813 | +86.8% | 0.01% | +250.0% |
Q1 2022 | $179,000 | -34.9% | 17,566 | +6.4% | 0.00% | -60.0% |
Q4 2021 | $275,000 | -50.4% | 16,516 | +39.6% | 0.01% | -64.3% |
Q3 2021 | $554,000 | +69.9% | 11,832 | +121.3% | 0.01% | +75.0% |
Q2 2021 | $326,000 | -30.2% | 5,347 | -29.4% | 0.01% | 0.0% |
Q1 2021 | $467,000 | +165.3% | 7,579 | +206.3% | 0.01% | +60.0% |
Q4 2020 | $176,000 | +38.6% | 2,474 | -26.6% | 0.01% | +400.0% |
Q3 2020 | $127,000 | -83.6% | 3,371 | -85.8% | 0.00% | -96.9% |
Q2 2020 | $775,000 | +1939.5% | 23,776 | +2067.4% | 0.03% | +966.7% |
Q4 2019 | $38,000 | +280.0% | 1,097 | +136.9% | 0.00% | +200.0% |
Q3 2019 | $10,000 | – | 463 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 6,068,125 | $160,016,456 | 65.94% |
Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $819,077,805 | 28.79% |
Cormorant Asset Management, LP | 4,662,530 | $122,950,916 | 7.17% |
Frazier Life Sciences Management, L.P. | 2,725,949 | $71,883,275 | 4.77% |
Octagon Capital Advisors LP | 971,639 | $25,622,120 | 3.94% |
M28 Capital Management LP | 121,200 | $3,196,044 | 3.66% |
VIKING GLOBAL INVESTORS LP | 25,120,991 | $662,440,533 | 2.69% |
BOONE CAPITAL MANAGEMENT LLC | 313,381 | $8,263,857 | 2.61% |
Fernwood Investment Management, LLC | 235,620 | $6,213,299 | 2.23% |
SOUTHPORT MANAGEMENT, L.L.C. | 15,000 | $395,550 | 2.15% |